← Leaderboards
Walter Kisiel
University Of New Mexico
$2,592,046
Attributed
$2,592,046
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $262.5K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$2,592,046 · 1
By mechanism
R01$2,592,046 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of New Mexico
Same institution · by research overlap
- Laurie G Hudson$12,915,106
- Gary Allen Rosenberg$25,012,030
- Kimberly K Leslie$10,616,588
- Lorraine Marie Deck$362,500
- Hengameh Raissy$254,910
Others in their field
Top investigators on “Extracellular Matrix”
- Valerie Marie Weaver · University Of California, San Francisco$23,238,959
- Naftali Kaminski · Yale University$23,053,857
- Kristiina Vuori · Burnham Institute For Medical Research$21,402,128
- Paul Wesley Noble · Yale University$20,772,493
- Martin A. Schwartz · Yale University$19,622,975
- Buddy D Ratner · University Of Washington$19,514,039
Research focus
Extracellular MatrixHomeostasisBlood CoagulationScid MouseLaboratory MouseX Ray CrystallographyTissue /Cell CultureProtein Protein InteractionVascular EndotheliumSerine ProteinasesEnzyme InhibitorsThromboplastinExtracellular Matrix ProteinsProtein Structure FunctionGene ExpressionGenetic Regulatory ElementRecombinant ProteinsMutantMonoclonal AntibodyNeoplastic Cell Culture For Noncancer ResearchLaboratory RabbitEnzyme ComplexBiological ModelsModel Design /Development
Grant awards (9)
Type-2 Tissue Factor Pathway Inhibitor$248,898
R01 · FY2008 · HL · contact PI
Type-2 Tissue Factor Pathway Inhibitor$248,898
R01 · FY2007 · HL · contact PI
Type-2 Tissue Factor Pathway Inhibitor$256,332
R01 · FY2006 · HL · contact PI
Type-2 Tissue Factor Pathway Inhibitor$262,500
R01 · FY2005 · HL
Type-2 Tissue Factor Pathway Inhibitor$343,140
R01 · FY2004 · HL
TYPE-2 TISSUE FACTOR PATHWAY INHIBITOR$294,000
R01 · FY2003 · HL
TYPE-2 TISSUE FACTOR PATHWAY INHIBITOR$294,000
R01 · FY2002 · HL
TYPE-2 TISSUE FACTOR PATHWAY INHIBITOR$294,000
R01 · FY2001 · HL
TYPE-2 TISSUE FACTOR PATHWAY INHIBITOR$350,278
R01 · FY2000 · HL